Brief: Island Pharmaceuticals Says US Patent Granted For Isla-101
11/12/2024 01:01
Dec 11 (Reuters) - Island Pharmaceuticals Ltd ILA.AX :
* US PATENT GRANTED FOR ISLA-101
* KEY PATENT GRANTED BY UNITED STATES PATENT AND TRADEMARK
OFFICE
FOR ISLA-101
Further company coverage: ILA.AX
((Reuters.Briefs@thomsonreuters.com))
Recent news on Island Pharmaceuticals
See all newsBrief: Island Pharmaceuticals Says Pivotal Marburg Data Secured For Galidesivir FDA Pathway
Brief: Island Pharmaceuticals Posts Prelim FY Loss Attributable Of A$9.8 Million
Australia's Island Pharmaceuticals rises as company boosts Galidesivir production
Brief: Island Pharmaceuticals Boosts Galidesivir Supply As Ebola Surges
Island Pharmaceuticals hits seven-month high on Galidesivir approval for Ebola epidemic